Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, SI Sherman, A Marabotti, GL Clayman… - Human pathology, 2009 - Elsevier
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

[引用][C] Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L SANTARPIA - Hum Pathol, 2009 - cir.nii.ac.jp
Detection and molecular characterization of a novel BRAF activated domain mutation in
follicular variant of papillary thyroid carcinoma | CiNii Research CiNii 国立情報学研究所 学術 …

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, SI Sherman, A Marabotti, GL Clayman… - Human Pathology, 2009 - infona.pl
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

[引用][C] Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L SANTARPIA, SI SHERMAN, A MARABOTTI… - Human …, 2009 - pascal-francis.inist.fr
Detection and molecular characterization of a novel BRAF activated domain mutation in
follicular variant of papillary thyroid carcinoma CNRS Inist Pascal-Francis CNRS Pascal …

[PDF][PDF] Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma☆,☆☆

MD Libero Santarpia, SI Sherman, GL Clayman… - Human …, 2009 - academia.edu
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, SI Sherman, A Marabotti… - Human …, 2009 - pubmed.ncbi.nlm.nih.gov
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, SI Sherman, A Marabotti… - Human …, 2009 - mdanderson.elsevierpure.com
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.

L Santarpia, SI Sherman, A Marabotti… - Human …, 2009 - europepmc.org
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …

[引用][C] Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, SI Sherman, A Marabotti, GL Clayman… - Human Pathology, 2009 - elibrary.ru

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

L Santarpia, S Sherman, A Marabotti, G Clayman… - HUMAN …, 2009 - iris.unisa.it
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA
of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also …